DWIGHT OWENS: Open Payments
NPI 1518989433 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 10 payments from 4 companies in 2025. Trend: 2023 $48 · 2024 $1,690 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 7 | $148 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: UZEDY, Dyanavel XR, Ozempic, Onyda XR, CAPLYTA.
Industry payments across GA — which companies pay providers there.
